Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders

Clin Chem. 2006 Aug;52(8):1604-6. doi: 10.1373/clinchem.2006.070193.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Cognition Disorders / cerebrospinal fluid*
  • Cognition Disorders / diagnosis
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Longitudinal Studies
  • Nervous System Diseases / cerebrospinal fluid*
  • Nervous System Diseases / diagnosis
  • Peptide Fragments / cerebrospinal fluid*
  • Specimen Handling
  • Time Factors

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)